[go: up one dir, main page]

WO2008036157A3 - Traitement prophylactique et thérapeutique d'infections de grippe aviaire chez les animaux - Google Patents

Traitement prophylactique et thérapeutique d'infections de grippe aviaire chez les animaux Download PDF

Info

Publication number
WO2008036157A3
WO2008036157A3 PCT/US2007/017953 US2007017953W WO2008036157A3 WO 2008036157 A3 WO2008036157 A3 WO 2008036157A3 US 2007017953 W US2007017953 W US 2007017953W WO 2008036157 A3 WO2008036157 A3 WO 2008036157A3
Authority
WO
WIPO (PCT)
Prior art keywords
avian influenza
animals
prophylactic
therapeutic treatment
influenza infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/017953
Other languages
English (en)
Other versions
WO2008036157A2 (fr
Inventor
Hal Siegel
Michael K Wilhelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuneregen Biosciences Inc
Original Assignee
Immuneregen Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuneregen Biosciences Inc filed Critical Immuneregen Biosciences Inc
Priority to CA002660856A priority Critical patent/CA2660856A1/fr
Publication of WO2008036157A2 publication Critical patent/WO2008036157A2/fr
Publication of WO2008036157A3 publication Critical patent/WO2008036157A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des analogues de la substance P qui se révèlent utiles pour traiter et protéger des animaux contre la grippe aviaire. Les analogues de la substance P peuvent être administrés par inhalothérapie, par les voies intraveineuse, intramusculaire, sublinguale ou par d'autres méthodes. Il est possible de prévenir la grippe aviaire chez les animaux et de réduire l'incidence de la maladie par un traitement à base d'analogues de la substance P.
PCT/US2007/017953 2006-08-15 2007-08-14 Traitement prophylactique et thérapeutique d'infections de grippe aviaire chez les animaux Ceased WO2008036157A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002660856A CA2660856A1 (fr) 2006-08-15 2007-08-14 Traitement prophylactique et therapeutique d'infections de grippe aviaire chez les animaux

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US83763506P 2006-08-15 2006-08-15
US60/837,635 2006-08-15
US82872806P 2006-10-09 2006-10-09
US60/828,728 2006-10-09
US86690106P 2006-11-22 2006-11-22
US60/866,901 2006-11-22
US89900407P 2007-02-02 2007-02-02
US60/899,004 2007-02-02
US91537307P 2007-05-01 2007-05-01
US60/915,373 2007-05-01

Publications (2)

Publication Number Publication Date
WO2008036157A2 WO2008036157A2 (fr) 2008-03-27
WO2008036157A3 true WO2008036157A3 (fr) 2008-12-24

Family

ID=39201031

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/017953 Ceased WO2008036157A2 (fr) 2006-08-15 2007-08-14 Traitement prophylactique et thérapeutique d'infections de grippe aviaire chez les animaux

Country Status (2)

Country Link
CA (1) CA2660856A1 (fr)
WO (1) WO2008036157A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170065663A1 (en) * 2014-05-02 2017-03-09 New Amsterdam Sciences Substance and method for treating influenza

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003194A2 (fr) * 1996-07-23 1998-01-29 Witten Mark L Traitement a la substance p pour l'immunostimulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003194A2 (fr) * 1996-07-23 1998-01-29 Witten Mark L Traitement a la substance p pour l'immunostimulation

Also Published As

Publication number Publication date
CA2660856A1 (fr) 2008-03-27
WO2008036157A2 (fr) 2008-03-27

Similar Documents

Publication Publication Date Title
HK1198869A1 (en) Combination treatments for hepatitis c
WO2009065406A3 (fr) Nouveaux composés hydrocarbonés cycliques pour le traitement de maladies
BRPI0916235A2 (pt) composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX374396B (es) Rocio de fentanilo sublingual.
MX341883B (es) Composicion farmaceutica para el tratamiento y prevencion de canceres.
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
WO2009129470A3 (fr) Méthodes de traitement d'infections dues au virus de l'herpès
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
WO2011127333A3 (fr) Composés pour le traitement d'une maladie, pour l'administration, et pour des compositions pharmaceutiques
WO2007098106A3 (fr) Délivrance d'interféron-tau dans les voies respiratoires
BR112012008962A2 (pt) derivados espiro-condensados de ciclohexano como inibidores de hsl úteis para o tratamento de diabetes
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
EA201171273A1 (ru) Средство для профилактики и лечения высокопатогенных инфекционных заболеваний
WO2010045417A3 (fr) Polytherapies pour le traitement de l'obesite
WO2009109654A8 (fr) Nouveaux dérivés de 1-benzyl-3-hydroxyméthylindazole et leur utilisation dans le traitement des maladies basées sur l’expression de mcp-1 et cx3cr1
PH12013500559A1 (en) Combination therapy for treating hcv infection
WO2008045378A3 (fr) Traitement d'hyperbilirubinémie infantile en utilisant des faibles dosages de stannsoporfine
WO2008070010A3 (fr) Rétablissement après une attaque
BRPI1008103A2 (pt) " peptídeo de cadeia curta isolado, composição farmacêutica, compostos, método de evitar ou tratar doenças, medicamento para tratar/ reduzir condições médicas e uso dos compostos "
WO2005094554A3 (fr) Agents, methodes et traitements therapeutiques
WO2010045522A3 (fr) Thérapies de combinaison pour le traitement de l'obésité
WO2010138419A3 (fr) Matières et procédés de traitement d'infections virales
WO2009006246A8 (fr) Utilisation d'antagonistes des jonctions étanches pour traiter une plaie pulmonaire aiguë et le syndrome de détresse respiratoire aiguë
WO2009023356A3 (fr) Matériaux et procédés pour traiter les infections par le virus de la grippe

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07836793

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2660856

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A OF 15.05.2009

122 Ep: pct application non-entry in european phase

Ref document number: 07836793

Country of ref document: EP

Kind code of ref document: A2